Pfizer (PFE) Shares Repurchased (2010 - 2022)

Pfizer (PFE) has 11 years of Shares Repurchased data on file, last reported at $2.0 billion in Q4 2022.

• Shares Repurchased for Q4 2022 came in at $2.0 billion, changed N/A year-over-year; the trailing twelve-month figure through Oct 2023 was $2.0 billion (down 50.0% YoY), and the FY2022 annual result was $2.0 billion, changed N/A from the prior year.
• Shares Repurchased held at $2.0 billion in Q4 2022 per PFE's latest filing, from $2.0 billion in the prior quarter.
• Over five years, Shares Repurchased peaked at $8.9 billion in Q1 2019 and troughed at $1.1 billion in Q3 2018.
• A 3-year average of $4.2 billion and a median of $3.5 billion in 2018 frame the typical range for Shares Repurchased.
• The sharpest annual moves came in 2018 and 2019: Shares Repurchased rose 21.26% in 2018, then surged 46.21% in 2019.
• A 3-year view of Shares Repurchased shows it stood at $5.0 billion in 2018, then jumped by 76.24% to $8.9 billion in 2019, then sank by 77.44% to $2.0 billion in 2022.
• Business Quant data shows PFE's Shares Repurchased at $2.0 billion in Q4 2022, $2.0 billion in Q2 2022, and $8.9 billion in Q1 2019.